Abstract
Heterozygous missense mutations in the serine-threonine kinase receptor BMPR1B result typically in brachydactyly type A2 (BDA2), whereas mutations in the corresponding ligand GDF5 cause brachydactyly type C (BDC). Mutations in the GDF inhibitor Noggin (NOG) or activating mutations in GDF5 cause proximal symphalangism (SYM1). Here, we describe a novel mutation in BMPR1B (R486Q) that is associated with either BDA2 or a BDC/SYM1-like phenotype. Functional investigations of the R486Q mutation were performed and compared with the previously reported BDA2-causing mutation R486W and WT BMPR1B. Overexpression of the mutant receptors in chicken micromass cultures resulted in a strong inhibition of chondrogenesis with the R486Q mutant, showing a stronger effect than the R486W mutant. To investigate the consequences of the BMPR1B mutations on the intracellular signal transduction, we used stably transfected C2C12 cells and measured the activity of SMAD-dependent and SMAD-independent pathways. SMAD activation after stimulation with GDF5 was suppressed in both mutants. Alkaline phosphatase induction showed an almost complete loss of activation by both mutants. Our data extend the previously known mutational and phenotypic spectrum associated with mutations in BMPR1B. Disturbances of NOG-GDF5-BMPR1B signaling cascade can result in similar clinical manifestations depending on the quantitative effect and mode of action of the specific mutations within the same functional pathway.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Bell J : Treasury of Human Inheritance. London: Cambridge University Press, 1951, vol 5, pp 1–31.
Kornak U, Mundlos S : Genetic disorders of the skeleton: a developmental approach. Am J Hum Genet 2003; 73: 447–474.
Lehmann K, Seemann P, Stricker S et al: Mutations in bone morphogenetic protein receptor 1B cause brachydactyly type A2. Proc Natl Acad Sci USA 2003; 100: 12277–12282.
Everman DB, Bartels CF, Yang Y et al: The mutational spectrum of brachydactyly type C. Am J Med Genet 2002; 112: 291–296.
Polinkovsky A, Robin NH, Thomas JT et al: Mutations in CDMP1 cause autosomal dominant brachydactyly type C. Nat Genet 1997; 17: 18–19.
Storm EE, Kingsley DM : GDF5 coordinates bone and joint formation during digit development. Dev Biol 1999; 209: 11–27.
Baur ST, Mai JJ, Dymecki SM : Combinatorial signaling through BMP receptor IB and GDF5: shaping of the distal mouse limb and the genetics of distal limb diversity. Development 2000; 127: 605–619.
Gilboa L, Nohe A, Geissendorfer T, Sebald W, Henis YI, Knaus P : Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors. Mol Biol Cell 2000; 11: 1023–1035.
Nohe A, Hassel S, Ehrlich M et al: The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J Biol Chem 2002; 277: 5330–5338.
von Bubnoff A, Cho K : Intracellular BMP signaling regulation in vertebrates: pathway or network? Dev Biol 2001; 239: 1–14.
Seemann P, Schwappacher R, Kjaer KW et al: Activating and deactivating mutations in the receptor interaction site of GDF5 cause symphalangism or brachydactyly type A2. J Clin Invest 2005; 115: 2373–2381.
Schwabe GC, Turkmen S, Leschik G et al: Brachydactyly type C caused by a homozygous missense mutation in the prodomain of CDMP1. Am J Med Genet A 2004; 124: 356–363.
Gong Y, Krakow D, Marcelino J et al: Heterozygous mutations in the gene encoding noggin affect human joint morphogenesis. Nat Genet 1999; 21: 302–304.
Gao B, Guo J, She C et al: Mutations in IHH, encoding Indian hedgehog, cause brachydactyly type A-1. Nat Genet 2001; 28: 386–388.
Lutz M, Krieglstein K, Schmitt S et al: Nerve growth factor mediates activation of the Smad pathway in PC12 cells. Eur J Biochem 2004; 271: 920–931.
Korchynskyi O, ten Dijke P : Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J Biol Chem 2002; 277: 4883–4891.
Garamszegi N, Dore Jr JJ, Penheiter SG, Edens M, Yao D, Leof EB : Transforming growth factor beta receptor signaling and endocytosis are linked through a COOH terminal activation motif in the type I receptor. Mol Biol Cell 2001; 12: 2881–2893.
Wieser R, Wrana JL, Massague J : GS domain mutations that constitutively activate T beta R-I, the downstream signaling component in the TGF-beta receptor complex. EMBO J 1995; 14: 2199–2208.
Sammar M, Stricker S, Schwabe GC et al: Modulation of GDF5/BRI-b signalling through interaction with the tyrosine kinase receptor Ror2. Genes Cells 2004; 9: 1227–1238.
Acknowledgements
This work was supported by a grant to KL (LE1851) by the Deutsche Forschungsgemeinschaft. We thank Dr Lindemann for the retroviral construct EGIRT. Work in PK's laboratory was supported by BMBF (0312117). Recombinant GDF5 was a kind gift from BIOPHARM GmbH.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lehmann, K., Seemann, P., Boergermann, J. et al. A novel R486Q mutation in BMPR1B resulting in either a brachydactyly type C/symphalangism-like phenotype or brachydactyly type A2. Eur J Hum Genet 14, 1248–1254 (2006). https://doi.org/10.1038/sj.ejhg.5201708
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.ejhg.5201708
Keywords
This article is cited by
-
Suppression of apoptosis impairs phalangeal joint formation in the pathogenesis of brachydactyly type A1
Nature Communications (2024)
-
A novel variant in the ROR2 gene underlying brachydactyly type B: a case report
BMC Pediatrics (2022)
-
TGF-β and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease
Bone Research (2016)
-
Two novel disease-causing variants in BMPR1B are associated with brachydactyly type A1
European Journal of Human Genetics (2015)
-
Homozygous missense and nonsense mutations in BMPR1B cause acromesomelic chondrodysplasia-type Grebe
European Journal of Human Genetics (2014)
